Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.05% | 129.65 | 0.0% | $2878.82m | |
| BNGO | BioNano Genomics, Inc. | 21.30% | 8.43 | 0.0% | $1523.88m | |
| GILD | Gilead Sciences, Inc. | 1.49% | 63.33 | 1.0% | $663.26m | |
| AMGN | Amgen, Inc. | 1.59% | 245.49 | 1.3% | $599.79m | |
| CRSP | CRISPR Therapeutics AG | -4.84% | 199.88 | 0.6% | $544.48m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.03% | 156.70 | 2.0% | $501.25m | |
| NVAX | Novavax, Inc. | -1.96% | 127.43 | 92.9% | $480.66m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 517.93 | 2.7% | $480.32m | |
| ILMN | Illumina, Inc. | 1.43% | 376.35 | 3.5% | $384.71m | |
| BIIB | Biogen, Inc. | -1.59% | 275.84 | 1.7% | $366.50m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.25% | 225.55 | 1.9% | $350.25m | |
| BNTX | BioNTech SE | -4.03% | 101.59 | 0.0% | $316.33m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.47% | 90.32 | 13.8% | $296.56m | |
| OCGN | Ocugen, Inc. | 1.84% | 2.22 | 0.0% | $276.18m | |
| EDIT | Editas Medicine, Inc. | 0.29% | 76.14 | 7.9% | $256.07m |
Company Profile
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.